Björn Larsson is an experienced manager in management, marketing and business development, who has held various senior positions, most recently as CEO of Observe Medical ASA, listed on the Oslo Stock Exchange. He has extensive experience in medical technology previously from Dentsply, Medtronic and Mentice, as well as in pharmaceuticals and biotechnology at AstraZeneca and Novo Nordisk. He has extensive experience from commercializing life science startups, both in operational roles and in board assignments. Björn is currently chairman of the board of Alzinova AB, vice chairman of IML, and a board member of ADI Yoga AB. Björn is independent of the company and its major owners.